While oxytocin remains the first-line choice of uterotonics and is widely used to prevent PPH, its heat sensitivity and stringent temperature requirements during manufacturing, transportation, and storage pose significant challenges especially in LMICs [32, 33]. Here, OXT is linked to pulmonary arterial hypertension.